Scipher Medicine Plans Launch of Blood Test to Predict Rheumatoid Arthritis Treatment Response
The molecular test could help identify patients more likely to respond to abatacept, with early access expected in 2027.
Latest Articles
Editor's Top Picks
Broader Screening Criteria Double Positive Results for Primary Aldosteronism, Study Finds
A study of 60,449 lab results found that using broader screening thresholds doubled detection rates of primary aldosteronism compared to Endocrine Society guidelines, according to research in Hypertension.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
AI Model Uses Routine Pathology Slides to Predict Breast Cancer Recurrence Risk
In a study of 372 patients, the model closely matched results from a 70-gene genomic test and identified differences in long-term survival.
Equipment & Supply Spotlight
Hologic and Inpeco Partner to Connect Panther Systems with FlexLab X Automation in Europe
The partnership will allow clinical laboratories to integrate multiple Panther Systems into automated workflows designed to increase testing capacity and improve sample tracking.
News, Know-How & Standards
Disease Detection & Understanding
Hologic to Acquire Reveal Genomics to Expand Breast Cancer Genomic Testing Portfolio
Hologic has agreed to acquire Reveal Genomics, adding the HER2DX assay to its oncology diagnostics portfolio and expanding genomic testing options for breast cancer, according to a company statement.
